New-Onset Atrial Fibrillation in Adult Patients After Cardiac Surgery
New-Onset Atrial Fibrillation in Adult Patients After Cardiac Surgery
复制标题
DOI：
10.1007/s40140-019-00321-4
复制
发表时间：
2019-06-01
影响因子：
1.3
通讯作者：
O'Brien，Ben
中科院分区：
文献类型：
--
作者：
Burrage，Peter S.;Low，Ying H.;O'Brien，Ben
综述目的概述有关心脏手术后患者新发房颤（AF）的病理生理学、风险因素、预防和治疗的最新文献。最新发现AF是心脏手术后最常见的不良事件，具有显着的相关发病率、死亡率和经济成本。其原因是多因素的，将患者分为风险类别的模型正在发展，但尚未开发出一致的循证系统。预防和治疗这种并发症的药物和手术干预一直是一个正在进行的研究领域，最近的社会指南反映了这一点。SummaryIncubility仍然围绕如何最好地识别高风险AF患者，哪些干预措施应用于预防和治疗AF，以及哪些患者群体应接受这些干预措施。这些可用的策略的证据和他们在当代指南的地方进行了总结。
Purpose of ReviewAn overview of recent literature regarding pathophysiology, risk factors, prophylaxis, and treatment of new-onset atrial fibrillation (AF) in post-cardiac surgical patients.Recent FindingsAF is the most frequent adverse event after cardiac surgery with significant associated morbidity, mortality, and financial cost. Its causes are multifactorial, and models to stratify patients into risk categories are progressing but a consistent, evidence-based system has not yet been developed. Pharmacologic and surgical interventions to prevent and treat this complication have been an area of ongoing research and recent societal guidelines reflect this.SummaryInconsistencies remain surrounding how to best identify higher-risk AF patients, which interventions should be used to prevent and treat AF, and which patient groups should receive these interventions. The evidence for these available strategies and their place in contemporary guidelines are summarized.